AP2013007198A0 - Thieno [2,3-D] pyrimidine derivatives and their use to treat arrhythmia - Google Patents

Thieno [2,3-D] pyrimidine derivatives and their use to treat arrhythmia

Info

Publication number
AP2013007198A0
AP2013007198A0 AP2013007198A AP2013007198A AP2013007198A0 AP 2013007198 A0 AP2013007198 A0 AP 2013007198A0 AP 2013007198 A AP2013007198 A AP 2013007198A AP 2013007198 A AP2013007198 A AP 2013007198A AP 2013007198 A0 AP2013007198 A0 AP 2013007198A0
Authority
AP
ARIPO
Prior art keywords
thieno
pyrimidine derivatives
treat arrhythmia
arrhythmia
treat
Prior art date
Application number
AP2013007198A
Other languages
English (en)
Inventor
John Ford
Derek Edward John
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44071904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2013007198(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Xention Ltd filed Critical Xention Ltd
Publication of AP2013007198A0 publication Critical patent/AP2013007198A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2013007198A 2011-04-01 2012-03-29 Thieno [2,3-D] pyrimidine derivatives and their use to treat arrhythmia AP2013007198A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1105659.5A GB201105659D0 (en) 2011-04-01 2011-04-01 Compounds
PCT/GB2012/050710 WO2012131379A1 (en) 2011-04-01 2012-03-29 Thieno [2, 3 -d] pyrimidine derivatives and their use to treat arrhythmia

Publications (1)

Publication Number Publication Date
AP2013007198A0 true AP2013007198A0 (en) 2013-10-31

Family

ID=44071904

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007198A AP2013007198A0 (en) 2011-04-01 2012-03-29 Thieno [2,3-D] pyrimidine derivatives and their use to treat arrhythmia

Country Status (42)

Country Link
US (1) US9249155B2 (xx)
EP (1) EP2694518B1 (xx)
JP (1) JP5826374B2 (xx)
KR (1) KR20140023332A (xx)
CN (1) CN103492392B (xx)
AP (1) AP2013007198A0 (xx)
AR (1) AR088735A1 (xx)
AU (1) AU2012235882B2 (xx)
BR (1) BR112013025236A2 (xx)
CA (1) CA2831493A1 (xx)
CL (1) CL2013002789A1 (xx)
CO (1) CO6801756A2 (xx)
CR (1) CR20130488A (xx)
CU (1) CU24173B1 (xx)
CY (1) CY1117025T1 (xx)
DK (1) DK2694518T3 (xx)
EA (1) EA201301111A1 (xx)
EC (1) ECSP13012988A (xx)
ES (1) ES2558563T3 (xx)
GB (1) GB201105659D0 (xx)
GT (1) GT201300225A (xx)
HK (2) HK1193096A1 (xx)
HR (1) HRP20151340T1 (xx)
HU (1) HUE028438T2 (xx)
IL (1) IL228555A0 (xx)
MA (1) MA35064B1 (xx)
ME (1) ME02314B (xx)
MX (1) MX335937B (xx)
NI (1) NI201300100A (xx)
PE (1) PE20141021A1 (xx)
PL (1) PL2694518T3 (xx)
PT (1) PT2694518E (xx)
RS (1) RS54458B1 (xx)
RU (1) RU2013148627A (xx)
SG (1) SG193578A1 (xx)
SI (1) SI2694518T1 (xx)
SM (1) SMT201500322B (xx)
TN (1) TN2013000377A1 (xx)
TW (1) TWI516265B (xx)
UA (1) UA110131C2 (xx)
WO (1) WO2012131379A1 (xx)
ZA (1) ZA201307085B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150307532A1 (en) * 2012-11-20 2015-10-29 The Royal Institution For The Advancement Of Learning/Mcgill University Thienopyrimidine inhibitors of farnesyl and/or geranylgeranyl pyrophosphate synthase
EP3394056B1 (en) 2015-12-22 2021-04-14 Shy Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物
MX2019014875A (es) * 2017-06-21 2021-01-29 SHY Therapeutics LLC Compuestos que interaccionan con la superfamilia ras para el tratamiento de cancer, enfermedades inflamatorias, rasopatias y enfermedad fibrotica.

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH317906A (de) 1953-09-16 1956-12-15 Sandoz Ag Verfahren zur Herstellung von 1-Amino-4-oxyanthrachinonsulfonsäuren
US4196207A (en) 1977-05-23 1980-04-01 Ici Australia Limited Process for controlling eradicating or preventing infestations of animals by Ixodid ticks
AU521790B2 (en) 1977-05-23 1982-04-29 Ici Australia Limited Process for eradication of ticks
DD226893A1 (de) 1981-12-15 1985-09-04 Ralf Boehm Verfahren zur herstellung von arylaminosubstituierten thieno 2,3-d pyrimidinen
WO1997007119A1 (en) 1994-08-26 1997-02-27 Takeda Chemical Industries, Ltd. Thienopyrimidine derivatives, their production and use
IL112566A (en) 1994-02-10 2000-10-31 Wyeth John & Brother Ltd Substituted quinolinones and pharmaceutical compositions containing them
IL112567A (en) 1994-02-10 2000-02-29 Wyeth John & Brother Ltd Substituted quinolines their preparation and pharmaceutical compositions containing them
IL112569A (en) 1994-02-10 1999-12-22 Wyeth John & Brother Ltd Pharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation
IL112568A0 (en) 1994-02-10 1995-05-26 Wyeth John & Brother Ltd Substituted quinolines, their preparation and pharmaceutical compositions containing them
ATE242230T1 (de) 1996-07-26 2003-06-15 Nissan Chemical Ind Ltd Chroman derivate
US6083986A (en) 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
RU2116309C1 (ru) 1997-02-13 1998-07-27 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 4-[(бензо-2,1,3-тиадиазолил-4)амино]-5,6,7,8-тетрагидробензотиено [2,3-d]пиримидин, обладающий противогельминтной активностью при ларвальном альвеолярном эхинококкозе
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
JP2002517385A (ja) 1998-06-05 2002-06-18 イカゲン インク． カリウムチャネル阻害剤
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
US6194458B1 (en) 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
DE19929076A1 (de) 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
WO2001021610A1 (en) 1999-09-17 2001-03-29 Nissan Chemical Industries, Ltd. Benzopyran derivative
EP1214307B1 (en) 1999-09-24 2004-04-07 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6531495B1 (en) 1999-10-02 2003-03-11 Aventis Pharma Deutschland Gmbh 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
DE19947457A1 (de) 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6677371B1 (en) 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
US6458794B2 (en) 1999-12-21 2002-10-01 Icagen, Inc. Potassium channel inhibitors
WO2002024655A1 (en) 2000-09-20 2002-03-28 Merck & Co., Inc. Isoquinolinone potassium channel inhibitors
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10059418A1 (de) 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10060807A1 (de) 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) 2000-12-12 2002-06-20 Aventis Pharma Gmbh Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
KR20030071880A (ko) 2001-02-02 2003-09-06 메르크 파텐트 게엠베하 피라졸로[４,３-ｄ]피리미딘과 엔도델린 수용체 길항제또는 티에노피리미딘과 엔도델린 수용체 길항제를포함하여 이루어지는 약제학적 조성물
DE10104802A1 (de) 2001-02-02 2002-08-08 Merck Patent Gmbh Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (1)
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
DE10121003A1 (de) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10121002A1 (de) 2001-04-28 2002-11-14 Aventis Pharma Gmbh Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen
DE10128331A1 (de) 2001-06-12 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
KR100869897B1 (ko) 2001-06-25 2008-11-24 닛산 가가쿠 고교 가부시키 가이샤 부정맥 치료용 치환 벤조피란 유도체
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
CN1823071B (zh) * 2003-06-11 2012-12-19 润生有限公司 用作钾通道抑制剂的噻吩并嘧啶衍生物
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
CN1845918A (zh) * 2003-07-02 2006-10-11 沃泰克斯药物股份有限公司 可用作电压－门控离子通道调节剂的嘧啶
JP2007517793A (ja) 2004-01-06 2007-07-05 大正製薬株式会社 環状アミノ基によって置換されたチエノピリミジン及びチエノピリジン誘導体
JP2008505084A (ja) 2004-06-29 2008-02-21 アムゲン インコーポレイティッド フラノピリミジン
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
EP1879899B1 (en) 2004-12-09 2010-08-04 Xention Limited Thienopyridine derivatives as potassium channel inhibitors
WO2007084815A2 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica, N.V. Substituted thienopyrimidine kinase inhibitors
WO2007146284A2 (en) 2006-06-12 2007-12-21 Vertex Pharmaceuticals Incorporated Thienopyrimidines useful as modulators of ion channels
DE102009039893B4 (de) 2009-09-03 2012-03-29 Bundesanstalt für Materialforschung und -Prüfung (BAM) Verwendung eines Brennstoffs in einem selbstunterhaltenden pulsierenden Sauerstoff-Brennstoff-Verbrennungsprozess

Also Published As

Publication number Publication date
WO2012131379A1 (en) 2012-10-04
GB201105659D0 (en) 2011-05-18
HK1193806A1 (zh) 2014-10-03
IL228555A0 (en) 2013-12-31
AU2012235882B2 (en) 2015-08-06
RU2013148627A (ru) 2015-05-10
TN2013000377A1 (en) 2015-01-20
PE20141021A1 (es) 2014-08-30
JP5826374B2 (ja) 2015-12-02
US20140206703A1 (en) 2014-07-24
CU20130124A7 (es) 2014-01-29
NZ615621A (en) 2015-01-30
MX2013011301A (es) 2014-04-16
HRP20151340T1 (hr) 2016-02-26
CA2831493A1 (en) 2012-10-04
CU24173B1 (es) 2016-04-25
SMT201500322B (it) 2016-02-25
TW201244720A (en) 2012-11-16
EP2694518A1 (en) 2014-02-12
MA35064B1 (fr) 2014-04-03
BR112013025236A2 (pt) 2019-09-24
JP2014509637A (ja) 2014-04-21
US9249155B2 (en) 2016-02-02
CN103492392A (zh) 2014-01-01
CR20130488A (es) 2013-12-06
ZA201307085B (en) 2015-04-29
CL2013002789A1 (es) 2014-07-18
RS54458B1 (en) 2016-06-30
ES2558563T3 (es) 2016-02-05
DK2694518T3 (en) 2015-11-09
AU2012235882A1 (en) 2013-05-02
CY1117025T1 (el) 2017-04-05
HUE028438T2 (en) 2017-02-28
EP2694518B1 (en) 2015-10-07
TWI516265B (zh) 2016-01-11
NI201300100A (es) 2014-01-07
EA201301111A1 (ru) 2014-02-28
HK1193096A1 (zh) 2014-09-12
AR088735A1 (es) 2014-07-02
CN103492392B (zh) 2015-11-25
SI2694518T1 (sl) 2016-02-29
PT2694518E (pt) 2016-02-05
MX335937B (es) 2016-01-04
SG193578A1 (en) 2013-10-30
PL2694518T3 (pl) 2016-03-31
ECSP13012988A (es) 2013-12-31
GT201300225A (es) 2014-12-30
UA110131C2 (ru) 2015-11-25
ME02314B (me) 2016-06-20
KR20140023332A (ko) 2014-02-26
CO6801756A2 (es) 2013-11-29

Similar Documents

Publication Publication Date Title
HRP20171724T1 (hr) Imidazo[1,2-b]piridazin derivati kao inhibitori kinaze
IL235819A0 (en) Preparation of pyrrolo[b–3,2]pyridines
AP3417A (en) Pyrazolo [1,5-a] pyrimidines as antiviral agents
EP2751112A4 (en) SUBSTITUTED PYRAZOLO [3,4-D] PYRIMIDINES AND USES THEREOF
PT2794611T (pt) Pirazolo[1,5-a]pirimidinas como agentes antivirais
IL227526A0 (en) Derivatives of 6-cyclobutyl-1,5-dihydro-pyrazolo [3,4-d] pyrimidine-4-one and their use as a9pde inhibitors
HK1176236A1 (en) Thiazolo[5,4-d] pyrimidines and their use as agrochemicals [54-d]
AP3751A (en) Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
HK1200447A1 (en) 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors 1h-[2,3-b]
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
HK1209740A1 (en) Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use --[23-d] pi3k
ZA201307511B (en) Pyrido [2,3-b] pyrazine derivatives and their therapeutical uses
HK1193806A1 (zh) 噻吩並 嘧啶衍生物及其用於治療心律失常的用途
HK1205504A1 (en) Substituted pyrazolo[1,5-a]pyridines, their preparation and use as medicaments [1,5-a]
EP2835372A4 (en) THIOPHENE [2, 3-D] PYRIMIDINE DERIVATIVE AND METHOD OF PREPARATION AND USE
ZA201402226B (en) 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances